We are live on ! Find out more
VTYX

Ventyx Biosciences
VTYX

Delisted

VTYX was delisted on the 3rd of March, 2026.

Back to rankings

118 hedge funds and large institutions have $114M invested in Ventyx Biosciences in 2024 Q3 according to their latest regulatory filings, with 19 funds opening new positions, 44 increasing their positions, 30 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

47% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 30

9% more call options, than puts

Call options by funds: $314K | Put options by funds: $288K

6% more first-time investments, than exits

New positions opened: 19 | Existing positions closed: 18

1% more funds holding

Funds holding: 117 → 118 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

6.95% less ownership

Funds ownership: 81.21% → 74.26% (-6.9%)

13% less capital invested

Capital invested by funds: $132M → $114M (-$17.8M)

Holders
118
Holders Change
+1
Holders Change %
+0.85%
% of All Funds
1.69%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
19
Increased
44
Reduced
30
Closed
18
Calls
$314K
Puts
$288K
Net Calls
+$26K
Net Calls Change
+$252K

Top Buyers

Rank Fund Capital Flow
1
SCM
Sio Capital Management
New York
+$2.74M
2
UBS Group
UBS Group
Switzerland
+$2.7M
3
DM
Deerfield Management
New York
+$2.04M
4
Bank of America
Bank of America
North Carolina
+$1.11M
5
Goldman Sachs
Goldman Sachs
New York
+$1.09M

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$12.1M
2
Citadel Advisors
Citadel Advisors
Florida
-$3M
3
OM
Opaleye Management
Massachusetts
-$2.75M
4
PHP
Parkman Healthcare Partners
Connecticut
-$2.68M
5
SSA
Schonfeld Strategic Advisors
New York
-$1.66M
Name Holding Trade Value Shares
Change 		Change in
Stake
QUSVM
26
Qiming U.S. Ventures Management
Washington
$899K – – –
Walleye Capital
27
Walleye Capital
New York
$850K -$278K -120,730 -24%
Morgan Stanley
28
Morgan Stanley
New York
$725K -$685K -298,100 -47%
TCM
29
TCG Crossover Management
California
$689K – – –
Renaissance Technologies
30
Renaissance Technologies
New York
$684K +$721K +313,700 New
Millennium Management
31
Millennium Management
New York
$595K -$291K -126,433 -32%
Two Sigma Investments
32
Two Sigma Investments
New York
$577K +$64.6K +28,096 +12%
Acadian Asset Management
33
Acadian Asset Management
Massachusetts
$473K -$106K -45,907 -17%
BCM
34
Bridgeway Capital Management
Texas
$436K +$460K +200,000 New
UOC
35
UBS O'Connor
Illinois
$436K +$460K +200,000 New
IC
36
Ikarian Capital
Texas
$420K -$575K -250,000 -56%
Marshall Wace
37
Marshall Wace
United Kingdom
$389K +$410K +178,514 New
Bank of New York Mellon
38
Bank of New York Mellon
New York
$384K -$125K -54,291 -24%
N
39
Nuveen
North Carolina
$367K +$79K +34,376 +26%
Invesco
40
Invesco
Georgia
$320K -$934 -406 -0.3%
Fidelity Investments
41
Fidelity Investments
Massachusetts
$285K +$8.86K +3,854 +3%
XT
42
XTX Topco
Cayman Islands
$246K +$259K +112,713 New
AQR Capital Management
43
AQR Capital Management
Connecticut
$237K +$120K +52,210 +92%
D.E. Shaw & Co
44
D.E. Shaw & Co
New York
$233K +$39.8K +17,288 +19%
HighTower Advisors
45
HighTower Advisors
Illinois
$227K +$10.3K +4,500 +5%
AllianceBernstein
46
AllianceBernstein
Tennessee
$221K – – –
LP
47
LMR Partners
United Kingdom
$218K +$230K +100,000 New
ACM
48
ADAR1 Capital Management
Texas
$214K +$195K +85,000 +656%
RhumbLine Advisers
49
RhumbLine Advisers
Massachusetts
$201K +$3.87K +1,681 +2%
Barclays
50
Barclays
United Kingdom
$175K +$135K +58,776 +273%
1
2
3 4 5

VTYX Hedge Fund Activity: Q3 2024 in Review

118 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Ventyx Biosciences (VTYX) for Q3 2024, worth a combined $114M — down 13% from $132M a quarter earlier.

Buyers outnumbered sellers: 19 funds opened new VTYX positions and 18 closed out — a net gain of 1 holder — while 44 added to existing stakes and 30 trimmed.

The largest buyer was Sio Capital Management, adding an estimated $2.74M. The largest seller was Capital International Investors, exiting entirely with an estimated $12.1M sold.

  • 118 institutional investors held Ventyx Biosciences (VTYX) as of Q3 2024, up from 117 in Q2 2024.
  • Funds reported $114M of Ventyx Biosciences stock for Q3 2024, down 13% quarter-over-quarter.
  • 19 funds opened new Ventyx Biosciences positions in Q3 2024 and 18 closed out, a net change of +1 holder.
  • The largest Ventyx Biosciences buyer in Q3 2024 was Sio Capital Management, an estimated $2.74M added.
  • The largest Ventyx Biosciences seller in Q3 2024 was Capital International Investors, an estimated $12.1M sold.

Based on aggregated 13F filings for Q3 2024.